Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Strayer

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Human Pathology|January 28, 2004
New technologies in research and diagnosis: implications and opportunities for Human Pathology, its authors, and its readershipDavid S Strayer
Alcoholism, Clinical and Experimental Research|September 25, 2012
Raphael Rubin, 1956-2011David S Strayer
Virus Research|January 18, 2006
Using gene delivery to protect HIV-susceptible CNS cells: inhibiting HIV replication in microgliaPierre Cordelier, David S Strayer
Biochimica Et Biophysica Acta|July 25, 2003
Mechanisms of alpha1-antitrypsin inhibition of cellular serine proteases and HIV-1 protease that are essential for HIV-1 morphogenesisPierre Cordelier, David S Strayer
Thescientificworldjournal|March 27, 2012
Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implicationsJean-Pierre Louboutin, David S Strayer
Vaccine|September 26, 2002
Immune responses against SIV envelope glycoprotein, using recombinant SV40 as a vaccine delivery vectorHayley J McKee, David S Strayer
CNS & Neurological Disorders Drug Targets|September 20, 2013
Relationship between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and regeneration in a model of epilepsyJean-Pierre Louboutin, David S Strayer
Experimental Cell Research|November 5, 2002
Survival signaling in type II pneumocytes activated by surfactant protein-AMartyn K White, David S Strayer
Oligonucleotides|March 6, 2004
Targeting CCR5 with siRNAs: using recombinant SV40-derived vectors to protect macrophages and microglia from R5-tropic HIVPierre Cordelier, Barry Morse, David S Strayer
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 11, 2004
Conditional expression of IFN-alpha and IFN-gamma activated by HBV as genetic therapy for hepatitis BAlexey A Matskevich, Pierre Cordelier, David S Strayer
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Human Pathology|January 28, 2004
New technologies in research and diagnosis: implications and opportunities for Human Pathology, its authors, and its readershipDavid S Strayer
Alcoholism, Clinical and Experimental Research|September 25, 2012
Raphael Rubin, 1956-2011David S Strayer
Virus Research|January 18, 2006
Using gene delivery to protect HIV-susceptible CNS cells: inhibiting HIV replication in microgliaPierre Cordelier, David S Strayer
Biochimica Et Biophysica Acta|July 25, 2003
Mechanisms of alpha1-antitrypsin inhibition of cellular serine proteases and HIV-1 protease that are essential for HIV-1 morphogenesisPierre Cordelier, David S Strayer
Thescientificworldjournal|March 27, 2012
Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implicationsJean-Pierre Louboutin, David S Strayer
Vaccine|September 26, 2002
Immune responses against SIV envelope glycoprotein, using recombinant SV40 as a vaccine delivery vectorHayley J McKee, David S Strayer
CNS & Neurological Disorders Drug Targets|September 20, 2013
Relationship between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and regeneration in a model of epilepsyJean-Pierre Louboutin, David S Strayer
Experimental Cell Research|November 5, 2002
Survival signaling in type II pneumocytes activated by surfactant protein-AMartyn K White, David S Strayer
Oligonucleotides|March 6, 2004
Targeting CCR5 with siRNAs: using recombinant SV40-derived vectors to protect macrophages and microglia from R5-tropic HIVPierre Cordelier, Barry Morse, David S Strayer
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 11, 2004
Conditional expression of IFN-alpha and IFN-gamma activated by HBV as genetic therapy for hepatitis BAlexey A Matskevich, Pierre Cordelier, David S Strayer
Pageof 5